Skip to main content
×
Home

The AKP between populism and neoliberalism: lessons from pharmaceutical policy

  • Tim Dorlach (a1)
Abstract
Abstract

In September 2009, Turkey experienced a major reform of its pharmaceutical expenditure and price policy. By introducing a global budget, Turkey saved some 20 billion TL in public pharmaceutical expenditure in the 2010–2012 period. The lion’s share of this was achieved by introducing stricter price controls that reduced the profit margins of pharmaceutical producers and distributors (the populist policy solution), rather than by privatizing the cost of medicines through, for example, raising out-of-pocket payments (the neoliberal policy solution). This is a puzzle, given the Justice and Development Party (Adalet ve Kalkınma Partisi, AKP) government’s usual preference for lenient and business-friendly regulation. This article explains the policy reform with reference to (i) the pronounced electoral interests of the AKP’s political leadership in not substantially reducing access to public health services, (ii) the absence of powerful business interests in high medicine prices, and (iii) the absence of a developmentalist commitment to an industrial policy strategy for the pharmaceutical sector. This case study holds important lessons for scholars of Turkish politics. It suggests that externally the AKP’s economic and social policies are driven by the interests of its two major constituencies (namely, lower-class voters and “Anatolian capital”), while internally they are shaped by two camps of policy makers (namely, neoliberal-minded technocrats and election-focused party leaders).

Copyright
Footnotes
Hide All

Author’s Note: I thank Ayşe Buğra, İpek Eren Vural, Bünyamin Esen, Çağlar Keyder, Tracy Lord, Ziya Öniş, Yalçın Özkan, Osman Savaşkan, Umut Türem, Alper Yağcı, conference participants at the London School of Economics, Middle East Technical University, and the University of Sheffield, as well as three anonymous referees and the editors of this journal for comments that helped improve this paper.

Footnotes
References
Hide All
Acemoğlu Daron, Egorov Georgy, and Sonin Konstantin. “A Political Theory of Populism.” The Quarterly Journal of Economics 128, no. 2 (2013): 771805.
Ağartan Tuba I. “Marketization and Universalism: Crafting the Right Balance in the Turkish Healthcare System.” Current Sociology 60, no. 4 (2012): 456471.
Ağartan Tuba I. “Explaining Large-Scale Policy Change in the Turkish Health Care System: Ideas, Institutions, and Political Actors.” Journal of Health Politics, Policy and Law 40, no. 5 (2015): 967995.
Ağartan Tuba I. “Learn, Frame and Deploy? Cross-National Policy Ideas and Comparisons in Turkey’s Health Reform.” Journal of Comparative Policy Analysis: Research and Practice 18, no. 1 (2016): 5469.
Araştırmacı İlaç Firmaları Derneği (AİFD). “Letter to H.E. Prime Minister, Prof. Dr. Ahmet Davutoğlu, jointly signed by Turkish pharma industry representatives.” November 27, 2014. http://www.aifd.org.tr/en/Haber-Detay.aspx?NewsId=2935.
Araştırmacı İlaç Firmaları Derneği (AİFD).Türkiye İlaç Sektörü Vizyon 2023 Raporu. 2012. http://www.pwc.com.tr/tr/publications/industrial/pharma/pdf/ilac-sektoru-vizyon-2023-raporu.pdf.
AİFD, İlaç Endüstrisi İşverenler Sendikası (İEİS), and Türkiye İlaç Sanayi Derneği (TİSD). Orta Vadeli Program ve Bütçe Disiplini Açısından AİFD-İEİS-TİSD Ortak Model Önerisi (01.12.2009). 2009. http://www2.tbmm.gov.tr/d23/7/7-11343c.pdf.
Akıncı Fevzi, Mollahaliloğlu Salih, Gürsöz Hakkı and Öğücü Fatma. “Assessment of the Turkish Health Care System Reforms: A Stakeholder Analysis.” Health Policy 107, no. 1 (2012): 2130.
Alp Aysel. “Grip olan hastaneye gidemeyecek!” Hürriyet. September 16, 2009.
Ateş Hazal. “‘Kemer sıkma’ operasyonu başlıyor, ilk neşter sağlığa.” Sabah. September 3, 2009.
Ateş Leyla. “Domestic Political Legitimacy of Tax Reform in Developing Countries: A Case Study of Turkey.” Wisconsin International Law Journal 30, no. 3 (2012): 706760.
Ateş M. Rauf. “Sadece ilaç sektörü değil, eczacılar da isyanları oynuyor.” Hürriyet. October 1, 2009.
Aytaç S. Erdem and Öniş Ziya. “Varieties of Populism in a Changing Global Context: The Divergent Paths of Erdoğan and Kirchnerismo.” Comparative Politics 47, no. 1 (2014): 4159.
Barr Robert R. “Populists, Outsiders and Anti-establishment Politics.” Party Politics 15, no. 1 (2009): 2948.
Bozkurt Umut. “Neoliberalism with a Human Face: Making Sense of the Justice and Development Party’s Neoliberal Populism in Turkey.” Science & Society 77, no. 3 (2013): 372396.
Buğra Ayşe and Savaşkan Osman. “Politics and Class: The Turkish Business Environment in the Neoliberal Age.” New Perspectives on Turkey 46 (2012): 2763.
Buğra Ayşe and Savaşkan Osman.New Capitalism in Turkey: The Relationship between Politics, Religion and Business. Cheltenham: Edward Elgar, 2014.
Buğra Ayşe and Keyder Çağlar. “The Turkish Welfare Regime in Transformation.” Journal of European Social Policy 16, no. 3 (2006): 211228.
Brown Sarah. Hole Arne Risa and Kılıç Dilek. “Out-of-pocket Health Care Expenditure in Turkey: Analysis of the 2003–2008 Household Budget Surveys.” Economic Modelling 41 (2014): 211218.
Çakkal Ömer. “Adil Gür: Türk Halkı, Hükümetin en Başarılı İcraatı Olarak Sağlığı. Görüyor.” Sağlık Düşüncesi ve Tıp Kültürü Dergisi 18 (2011): 2631.
Çekirge Fatih. “Yeni önlem paketi geliyor.” Hürriyet. August 31, 2009.
Çelik Aziz. “Turkey’s New Labour Regime under the Justice and Development Party in the First Decade of the Twenty-first Century: Authoritarian Flexibilization.” Middle Eastern Studies 51, no. 4 (2015): 618635.
Dalan Necla. “200 milyon $ yatıracak ‘jenerik’te ilk 5’e girecek.” Vatan. August 23, 2014.
Demiralp Seda. “The Rise of Islamic Capital and the Decline of Islamic Radicalism in Turkey.” Comparative Politics 41, no. 3 (2009): 315335.
Demirkan Özge. “Bakana baskı.” Vatan. January 27, 2003.
Dorlach Tim. “The Prospects of Egalitarian Capitalism in the Global South: Turkish Social Neoliberalism in Comparative Perspective.” Economy and Society 44, no. 4 (2015): 519544.
Düzel Neşe. “İlaççılar IMF’yi bile devreye soktu.” Radikal. August 16, 2004.
Eder Mine. “Deepening Neoliberalization and a Changing Welfare Regime in Turkey.” Turkey’s Democratization Process. Edited by Carmen Rodriguez, Antonio Ávalos, Hakan Yılmaz, and Ana I. Planet. Abingdon and New York: Routledge, 2013. 195220.
Edwards Sebastian. Left Behind: Latin America and the False Promise of Populism. Chicago: University of Chicago Press, 2010.
Eren Vural İpek. “Domestic Contours of Global Regulation: Understanding the Policy Changes on Pharmaceutical Patents in India and Turkey.” Review of International Political Economy 14, no. 1 (2007): 105142.
Eren Vural İpekNeoliberalism, Intellectual Property Rights and the Turkish Pharmaceutical Industry in the 2000s.” In The New Political Economy of Pharmaceuticals Production, Innovation and TRIPs in the Global South. Edited by Hans Löfgren and Owain David Williams. Basingstoke: Palgrave Macmillan, 2013. 221245.
Eren Vural İpek. “Politics, Reforms, and Regulation of Pharma Prices and Expenditures in Turkey over the 2000s.” In Pharmaceutical Prices in the 21st Century. Edited by Zaheer-Ud-Din Babar. Cham: Springer International, 2015. 267296.
Erus Burçay and Aktakke Nazlı. “Impact of Healthcare Reforms on Out-of-pocket Health Expenditures in Turkey for Public Insurees.” The European Journal of Health Economics 13, no. 3 (2012): 337346.
Erus Burçay, Yakut-Çakar Burcu, Cali Sanda and Adaman Fikret. “Health Policy for the Poor: An Exploration on the Take-Up of Means-Tested Health Benefits in Turkey.” Social Science & Medicine 130 (2015): 99106.
Espin Jaim, Rovira Joan and de Labry Antonio Olry. “External Reference Pricing.” WHO/HAI Project on Medicine Prices and Availability, 2011.
Fearon James D.Counterfactuals and Hypothesis Testing in Political Science.” World Politics 43, no. 2 (1991): 169195.
Fisher Ellison Sara and Wolfram Catherine. “Coordinating on Lower Prices: Pharmaceutical Pricing under Political Pressure.” The Rand Journal of Economics 37, no. 2 (2006): 324340.
Gereffi Gary. The Pharmaceutical Industry and Dependency in the Third World. Princeton, NJ: Princeton University Press, 1983.
Gidron Noam and Bonikowski Bart. “Varieties of Populism: Literature Review and Research Agenda”. Weatherhead Center Working Paper Series. Cambridge, MA: Weatherhead Center for International Affairs, 2013.
Göçmen Ipek. “Religion, Politics and Social Assistance in Turkey: The Rise of Religiously Motivated Associations.” Journal of European Social Policy 24, no. 1 (2014): 92103.
Gürcanlı Zeynep. “Başbakan ‘milli ilaç’ istedi.” Hürriyet. January 19, 2013.
Güven Ali Burak. “Rethinking Development Space in Emerging Countries: Turkey’s Conservative Countermovement.” Development and Change 47, no. 5 (2016): 9951024.
Hale William and Özbudun Ergun. Islamism, Democracy and Liberalism in Turkey: The Rise of the AKP. London: Routledge, 2010.
Hay Colin. “Ideas and the Construction of Interests.” In Ideas and Politics in Social Science Research. Edited by Daniel Béland and Robert H. Cox. New York: Oxford University Press, 2011. 90114.
Hill Raymond and Chui Mandy. “The Pharmerging Future.” Pharmaceutical Executive 29, no. 7 (2009).
Hürriyet . “Dolar düştüithal ilaç ucuzlamadı.” January 11, 2004.
Hürriyet . “Kanser ilacı ucuzlayacak.” January 18, 2004.
Hürriyet . “İthal ilaçlar ucuzluyor.” January 29, 2004.
Hürriyet . “45 milyon kişin ilaççilesine son veren imza.” December 15, 2004.
Hürriyet . “İlaç sektörünün önü açık.” February 3, 2009.
Hürriyet . “IMF’den orta vadeli programa ‘cesaret verici’ mesajı geldi.” September 18, 2009.
Hürriyet . “İlaç krizi çözüldü.” December 19, 2011.
İlaç Endüstrisi İşverenler Sendikası (İEİS). Partnering with the Government to Globalize the Turkish Pharmaceutical Industry. İstanbul: Pharmaceutical Manufacturers Association of Turkey, 2011.
İlaç Endüstrisi İşverenler Sendikası (İEİS). “Türkiye İlaç Endüstrisi’nin Küreselleşmesi için Devlet ile Ortak Yol Haritası.” 2011.
Karataşlı Şahan Savaş. “The Origins of Turkey’s ‘Heterodox’ Transition to Neoliberalism: The Özal Decade and Beyond.” Journal of World-Systems Research 21, no. 2 (2015): 387416.
Keyder Çağlar, Üstündağ Nazan, Ağartan Tuba and Yoltar Çağrı, eds. Avrupa’da ve Türkiye’de Sağlık Politikaları. İstanbul: İletişim, 2007.
Medimagazin . “Sağlık harcaması son 9 yılda yüzde 40 arttı.” September 14, 2009.
Milliyet . “Bütçe açık verirse versin.” September 3, 2009.
Milliyet . “Çember daralıyor, varlık barışından yararlanın.” September 7, 2009.
ntvmsnbc. “Ekonomi yönetimi sosyal güvenliği görüşüyor.” September 4, 2009.
Organisation for Economic Co-operation and Development (OECD). Pharmaceutical Pricing Policies in a Global Market. 2008. http://apps.who.int/medicinedocs/documents/s19834en/s19834en.pdf.
Ökem Zeynep Güldem and Çakar Mehmet. “What Have Health Care Reforms Achieved in Turkey? An Appraisal of the ‘Health Transformation Programme.’Health Policy 119 (2015): 11531163.
Öniş Ziya. “The Political Economy of Turkey in the 1980s: The Anatomy of Unorthodox Liberalism.” In Strong State and Economic Interest Groups: The Post-1980 Turkish Experience. Edited by Metin Heper. New York and London: Walter de Gruyter, 1991. 2740.
Öniş Ziya. “Power, Interests and Coalitions: The Political Economy of Mass Privatisation in Turkey.” Third World Quarterly 32, no. 4 (2011): 707724.
Öniş Ziya. “The Triumph of Conservative Globalism: The Political Economy of the AKP Era.” Turkish Studies 13, no. 2 (2012): 135152.
Öniş Ziya and Burak Güven Ali. “Global Crisis, National Responses: The Political Economy of Turkish Exceptionalism.” New Political Economy 16, no. 5 (2011): 585608.
Öniş Ziya and Şenses Fikret, eds. Turkey and the Global Economy: Neo-Liberal Restructuring and Integration in the Post-Crisis Era. London: Routledge, 2009.
Özcan Gül Berna and Gündüz Umut. “Political Connectedness and Business Performance: Evidence from Turkish Industry Rankings.” Business and Politics 17, no. 1 (2015): 4173.
Özcan Gül Berna and Gündüz Umut.“Energy Privatisations, Business-Politics Connections and Governance under Political Islam.” Environment and Planning C: Government and Policy 33, no. 6 (2015): 17141737.
Özpeynirci Emre. “Pfizer, 80 milyon dolarlık rest çekti.” Hürriyet. May 11, 2002.
Pierson Paul. “Big, Slow-Moving, and … Invisible: Macrosocial Processes in the Study of Comparative Politics.” In Comparative Historical Analysis in the Social Sciences. Edited by James Mahoney and Dietrich Rueschemeyer. New York: Cambridge University Press, 2003. 177207.
PricewaterhouseCoopers. “Pharmaceutical Deals: Mergers and Acquisitions Activity within the Turkish Pharmaceutical Market, 2006–2009 Review.” 2009. https://www.pwc.com/gx/en/pharma-life-sciences/pdf/pwc-pharmacy09.pdf.
Roberts Kenneth. “Neoliberalism and the Transformation of Populism in Latin America: The Peruvian Case.” World Politics 48, no. 1 (1995): 82116.
Rovira Kaltwasser Cristóbal. “Latin American Populism: Some Conceptual and Normative Lessons.” Constellations 21, no. 4 (2014): 494504.
Sabah. “Erdoğan düğmeye bastı Uludere olayı araştırılıyor.” January 5, 2012.
Sanyer Ruhi, “İlaççılar orta yol peşine düştü.” Radikal. May 6, 2002.
Sanyer Ruhi, “Pfizer’den Ankara turu.” Radikal. May 10, 2002.
Shadlen Kenneth and da Fonseca Elize Massard. “Health Policy as Industrial Policy Brazil in Comparative Perspective.” Politics & Society 41, no. 4 (2013): 561587.
T.C. Sağlık Bakanlığı. Sağlıkta Dönüşüm. Ankara: Ministry of Health, 2003.
T.C. Sosyal Güvenlik Kurumu (SGK). Sosyal Güvenlik Kurumu Sağlık Uygulama Tebliği. Adopted June 15, 2007. Resmi Gazete 26532 (Mükerrer). May 25, 2007.
T.C. Sosyal Güvenlik Kurumu (SGK), Sosyal Güvenlik Kurumu Sağlık Uygulama Tebliğinde Değişiklik Yapılmasına Dair Tebliği. Adopted February 29, 2012.
Top Mehmet and Tarcan Menderes. “Türkiye İlaç Ekonomisi ve İlaç Harcamaları: 1998–2003 Dönemi Değerlendirmesi.” Liberal Düşünce 35 (2004): 177200.
Tuğal Cihan. Passive Revolution: Absorbing the Islamic Challenge to Capitalism. Stanford, CA: Stanford University Press, 2009.
Weyland Kurt. “Neoliberal Populism in Latin America and Eastern Europe.” Comparative Politics 31, no. 4 (1999): 379401.
Wikileaks. “Turkey: Compromise Deal Reached on Pharma, but Industry, Pharmacists Still Angry.” Cable no. 09ANKARA1740_a. December 7, 2009.
World Health Organization (WHO). Turkey: Country Cooperation Strategy at a Glance. Geneva: World Health Organization, 2013.
Yenimahalleli Yaşar Gülbiye. “‘Health Transformation Programme’ in Turkey: An Assessment.” International Journal of Health Planning and Management 26, no. 2 (2011): 110133.
Yıldırım Deniz. “AKP ve Neoliberal Popülizm.” In AKP Kitabı: Bir Dönüşümün Bilançosu. Edited by Bülent Duru, and İlhan Uzel. Ankara: Phoenix, 2009. 66107.
Yılmaz Volkan. “Changing Origins of Inequalities in Access to Health Care Services in Turkey: From Occupational Status to Income.” New Perspectives on Turkey 48 (2013): 5577.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

New Perspectives on Turkey
  • ISSN: 0896-6346
  • EISSN: 1305-3299
  • URL: /core/journals/new-perspectives-on-turkey
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 21
Total number of PDF views: 115 *
Loading metrics...

Abstract views

Total abstract views: 563 *
Loading metrics...

* Views captured on Cambridge Core between 9th January 2017 - 14th December 2017. This data will be updated every 24 hours.